{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20131108",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "17559",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022416s000lbl.pdf",
              "date": "20131115",
              "type": "Label"
            },
            {
              "id": "22016",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022416Orig1s000TOC.html",
              "date": "20131220",
              "type": "Review"
            },
            {
              "id": "24301",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022416Orig1s000TOC.html",
              "date": "20131220",
              "type": "Summary Review"
            },
            {
              "id": "29701",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022416Orig1s000ltr.pdf",
              "date": "20131113",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20170307",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "47510",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022416Orig1s006ltr.pdf",
              "date": "20170308",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20150910",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20150611",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20240620",
          "review_priority": "N/A",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "79547",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022416Orig1s021lbl.pdf",
              "date": "20240906",
              "type": "Label"
            },
            {
              "id": "79550",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/022416Orig1s021ltr.pdf",
              "date": "20240906",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20190315",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "58012",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022416Orig1s011ltr.pdf",
              "date": "20190318",
              "type": "Letter"
            },
            {
              "id": "58026",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf",
              "date": "20190318",
              "type": "Label"
            },
            {
              "id": "58027",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25",
              "date": "20190318",
              "type": "Medication Guide"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20170913",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "49733",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022416s009lbl.pdf",
              "date": "20170914",
              "type": "Label"
            },
            {
              "id": "49814",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022416Orig1s009ltr.pdf",
              "date": "20170920",
              "type": "Letter"
            },
            {
              "id": "52480",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/198_22416S009 eslicarbazepine CDTL clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric CDTL Review"
            },
            {
              "id": "52481",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/199_22416S009 eslicarbazepine clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "52482",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/200_22416S009 eslicarbazepine clinpharm prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20160106",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20150827",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "38676",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022416s001lbl.pdf",
              "date": "20150828",
              "type": "Label"
            },
            {
              "id": "29702",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022416Orig1s001ltr.pdf",
              "date": "20150901",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA022416",
      "sponsor_name": "SUMITOMO PHARMA AM",
      "openfda": {
        "application_number": [
          "NDA022416"
        ],
        "brand_name": [
          "APTIOM"
        ],
        "generic_name": [
          "ESLICARBAZEPINE ACETATE"
        ],
        "manufacturer_name": [
          "Sumitomo Pharma America, Inc."
        ],
        "product_ndc": [
          "63402-202",
          "63402-204",
          "63402-206",
          "63402-208",
          "63402-248"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ESLICARBAZEPINE ACETATE"
        ],
        "rxcui": [
          "1482507",
          "1482513",
          "1482515",
          "1482517",
          "1482521",
          "1482523",
          "1482525",
          "1482527",
          "1491642",
          "1491643"
        ],
        "spl_id": [
          "3af99c5d-50e2-4336-8a5e-e93b6cf3618a"
        ],
        "spl_set_id": [
          "3d0c9554-eaeb-4694-8089-00133fcadce3"
        ],
        "package_ndc": [
          "63402-202-30",
          "63402-202-07",
          "63402-202-28",
          "63402-204-30",
          "63402-204-07",
          "63402-204-28",
          "63402-206-60",
          "63402-206-07",
          "63402-206-28",
          "63402-208-30",
          "63402-208-07",
          "63402-208-28",
          "63402-248-14",
          "63402-248-56",
          "63402-204-17",
          "63402-208-17"
        ],
        "unii": [
          "BEA68ZVB2K"
        ]
      },
      "products": [
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "APTIOM",
          "active_ingredients": [
            {
              "name": "ESLICARBAZEPINE ACETATE",
              "strength": "600MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "APTIOM",
          "active_ingredients": [
            {
              "name": "ESLICARBAZEPINE ACETATE",
              "strength": "200MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "004",
          "reference_drug": "Yes",
          "brand_name": "APTIOM",
          "active_ingredients": [
            {
              "name": "ESLICARBAZEPINE ACETATE",
              "strength": "800MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "APTIOM",
          "active_ingredients": [
            {
              "name": "ESLICARBAZEPINE ACETATE",
              "strength": "400MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}